Correlation
The correlation between LMAT and UTHR is 0.27, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
LMAT vs. UTHR
Compare and contrast key facts about LeMaitre Vascular, Inc. (LMAT) and United Therapeutics Corporation (UTHR).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: LMAT or UTHR.
Performance
LMAT vs. UTHR - Performance Comparison
Loading data...
Key characteristics
LMAT:
0.15
UTHR:
0.57
LMAT:
0.36
UTHR:
0.94
LMAT:
1.05
UTHR:
1.14
LMAT:
0.12
UTHR:
0.58
LMAT:
0.27
UTHR:
1.26
LMAT:
12.49%
UTHR:
14.62%
LMAT:
35.16%
UTHR:
31.71%
LMAT:
-75.69%
UTHR:
-93.18%
LMAT:
-23.50%
UTHR:
-22.23%
Fundamentals
LMAT:
$1.86B
UTHR:
$14.38B
LMAT:
$1.97
UTHR:
$25.09
LMAT:
41.73
UTHR:
12.71
LMAT:
2.15
UTHR:
1.43
LMAT:
8.21
UTHR:
4.80
LMAT:
5.34
UTHR:
2.11
LMAT:
$226.26M
UTHR:
$2.99B
LMAT:
$155.66M
UTHR:
$2.66B
LMAT:
$61.61M
UTHR:
$1.56B
Returns By Period
In the year-to-date period, LMAT achieves a -10.35% return, which is significantly lower than UTHR's -9.63% return. Over the past 10 years, LMAT has outperformed UTHR with an annualized return of 24.14%, while UTHR has yielded a comparatively lower 5.77% annualized return.
LMAT
-10.35%
4.70%
-22.80%
5.08%
22.74%
26.24%
24.14%
UTHR
-9.63%
8.23%
-13.94%
15.89%
11.45%
22.01%
5.77%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
LMAT vs. UTHR — Risk-Adjusted Performance Rank
LMAT
UTHR
LMAT vs. UTHR - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for LeMaitre Vascular, Inc. (LMAT) and United Therapeutics Corporation (UTHR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
LMAT vs. UTHR - Dividend Comparison
LMAT's dividend yield for the trailing twelve months is around 0.88%, while UTHR has not paid dividends to shareholders.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
LMAT LeMaitre Vascular, Inc. | 0.88% | 0.69% | 0.99% | 1.09% | 0.88% | 0.94% | 0.95% | 1.18% | 0.69% | 0.71% | 0.93% | 1.83% |
UTHR United Therapeutics Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
LMAT vs. UTHR - Drawdown Comparison
The maximum LMAT drawdown since its inception was -75.69%, smaller than the maximum UTHR drawdown of -93.18%. Use the drawdown chart below to compare losses from any high point for LMAT and UTHR.
Loading data...
Volatility
LMAT vs. UTHR - Volatility Comparison
LeMaitre Vascular, Inc. (LMAT) has a higher volatility of 16.24% compared to United Therapeutics Corporation (UTHR) at 8.09%. This indicates that LMAT's price experiences larger fluctuations and is considered to be riskier than UTHR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
LMAT vs. UTHR - Financials Comparison
This section allows you to compare key financial metrics between LeMaitre Vascular, Inc. and United Therapeutics Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
LMAT vs. UTHR - Profitability Comparison
LMAT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, LeMaitre Vascular, Inc. reported a gross profit of 41.42M and revenue of 59.87M. Therefore, the gross margin over that period was 69.2%.
UTHR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, United Therapeutics Corporation reported a gross profit of 701.90M and revenue of 794.40M. Therefore, the gross margin over that period was 88.4%.
LMAT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, LeMaitre Vascular, Inc. reported an operating income of 12.63M and revenue of 59.87M, resulting in an operating margin of 21.1%.
UTHR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, United Therapeutics Corporation reported an operating income of 382.80M and revenue of 794.40M, resulting in an operating margin of 48.2%.
LMAT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, LeMaitre Vascular, Inc. reported a net income of 11.01M and revenue of 59.87M, resulting in a net margin of 18.4%.
UTHR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, United Therapeutics Corporation reported a net income of 322.20M and revenue of 794.40M, resulting in a net margin of 40.6%.